With GlobalData figures showing the value of pharma’s 2023 digital therapeutics-...
UKHSA has signed an advance purchase agreement (APA) with healthcare company CSL...
“The truth is in many ways and many places, women have very little choice to obt...
After a drawn out lobbying fight, ARPA-H chose its headquarters: a hub and spoke...
Humira made an average $14.6 billion a year after the end of its primary patent,...
Sen. Bob Menendez (D-N.J.), who's embroiled in a financial scandal, is one of th...
Cambridge, Dallas, and Washington, D.C. were chosen as the three national hubs f...
There are a slew of federal programs and staff that could see work stalled this ...
Nurses and health care support workers have a higher risk of suicide than the ge...
If U.S. lawmakers are unable to prevent a government shutdown by Oct. 1, the FDA...
The latest rollout of Covid vaccines has been bumpy — but not unexpected — exper...
Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease ...
Results from an early study of an autoimmune disease drug from Roivant Sciences’...
Ionis Pharmaceuticals said its drug against familial chylomicronemia syndrome, a...
About a third of Medicare and Medicaid spending goes toward the 15% of beneficia...
There is no evidence to suggest that the current regulatory framework inhibits b...
